Page 79 - Read Online

Cohort studies and meta-analyses suggest that high coffee Milicevic M. Hepatocellular carcinoma: from clinical practice to
intake might prevent the HCC in subgroups of patients at evidence-based treatment protocols. World J Hepatol 2015;7:2274-
increased risk. Nevertheless, the mechanisms involved and the 5. 91.
European Association for the Study of the Liver; European
specific components of coffee beverages that may determine Organisation for Research and Treatment of Cancer. EASL-
this sort of protection are unknown. The available studies EORTC clinical practice guidelines: management of hepatocellular
often report different cut-offs of coffee intake, besides not carcinoma. J Hepatol 2012;56:908-43.
taking into account many potential confounders. Moreover, 6. Bruix J, Sherman M. Management of hepatocellular carcinoma: an
update. Hepatology 2011;53:1020-2.
registration of coffee consumption depends mainly on the 7. Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida
self-reporting questionarries with intrinsic relevant statistical HY, Kudo M, Lee JM, Choi BI, Poon RTP, Shiina S, Cheng AL,
limits. Consequently, it is difficult to establish the temporal Jia JD, Obi S, Han KH, Jafri W, Chow P, Lim SG, Chawla YK,
relationship between coffee use, liver disease and HCC onset. Budihusodo U, Gani RA, Lesmana CR, Putranto TA, Liaw YF,
Indeed, the open questions are the following: how much Sarin SK. Asian Pacific Association for the Study of the Liver
consensus recommendations on hepatocellular carcinoma. Hepatol
coffee is necessary and for how long time? Which is the long- Int 2010;4:439-74.
term safety profile of high-dose caffeine? 8. La Vecchia C. Coffee, liver enzymes, cirrhosis and liver cancer. J
Hepatol 2005;42:444-6.
Concerning TCM, many authors proposed it, alone or in 9. Cavin C, Holzhauser D, Constable A, Huggett AC, Schilter B. The
association with standard therapy. Notably, the studies coffee specific diterpenes cafestol and kahweol protect against
proposing TCM approach alone for the treatment of HCC show aflatoxin B1-induced genotoxicity through a dual mechanism.
Carcinogenesis 1998;19:1369-75.
no strong data. The TCM treatment obtains some interesting 10. Majer BJ, Hofer E, Cavin C, Lhoste E, Uhl M, Glatt HR, Meinl
results if administered together with TACE. In particular, W, Knasmüller S. Coffee diterpenes prevent the genotoxic effects
RCTs and meta-analyses demonstrate an advantage in terms of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and
of both patients’ survival and quality of life in comparison N-nitrosodimethylamine in a human derived liver cell line (HepG2).
Food Chem Toxicol 2005;43:433-41.
with the Western approach alone. However, there are many 11. Huber WW, Parzefall W. Modification of N-acetyltransferases and
unclear aspects: which single product of the TCM large family glutathione S-transferases by coffee components: possible relevance
is the best? Which is the impact of TCM on the liver function? for cancer risk. Methods Enzymol 2005;401:307-41.
Which is the safety profile of each TCM product? 12. Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the
risk of elevated serum alanine aminotransferase activity in the United
States. Gastroenterology 2005;128:24-32.
Many basic studies suggest that cannabis could block cell 13. Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected
proliferation, reduce cell migration and inhibit angiogenesis effects of coffee consumption on liver enzymes. Eur J Epidemiol
thus showing an anticancer attitude. Several data show 1993;9:293-7.
a relationship between PPAR receptor and autophagy- 14. Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis.
Am J Epidemiol 1992;136:1248-57.
essential proteins in HCC but the mechanisms involved in 15. Klatsky AL, Armstrong MA, Friedman GD. Coffee, tea, and
the antineoplastic action of cannabinoids are still debated. mortality. Ann Epidemiol 1993;3:375-81.
Furthermore, the lack of data on humans makes difficult to 16. Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO,
consider these substances as therapeutic choices. Trichopoulos D, Stuver SO. Tobacco smoking, alcohol consumption
and their interaction in the causation of hepatocellular carcinoma. Int
J Cancer 2000;85:498-502.
It may be that the described natural products could have a 17. La Vecchia C, Ferraroni M, Negri E, D’Avanzo B, Decarli A, Levi
future in the prevention of HCC, in the strengthening of the F, Franceschi F. Coffee consumption and digestive tract cancers.
standard therapy and in the palliative phase. Still, further Cancer Res 1989;49:1049-51.
RCTs with strong results are mandatory for their effective 18. Gelatti U, Covolo L, Franceschini M, Pirali F, Tagger A, Ribero ML,
broad application. Trevisi P, Martelli C, Nardi G, Donato F; Brescia HCC Study Group.
Coffee consumption reduces the risk of hepatocellular carcinoma
Financial support and sponsorship independently of its aetiology: a case-control study. J Hepatol
2005;42:528-34.
Nil. 19. Montella M, Polesel J, La Vecchia C, Dal Maso L, Crispo A, Crovatto
M, Casarin P, Izzo F, Tommasi LG, Talamini R, Franceschi S. Coffee
Conflicts of interest and tea consumption and risk of hepatocellular carcinoma in Italy. Int
There are no conflicts of interest. J Cancer 2007;120:1555-9.
20. Tanaka K, Hara M, Sakamoto T, Higaki Y, Mizuta T, Eguchi
Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S,
REFERENCES Shigematsu H, Koizumi S. Inverse association between coffee
drinking and the risk of hepatocellular carcinoma: a case-control
1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global study in Japan. Cancer Sci 2007;98:214-8.
cancer statistics. CA Cancer J Clin 2011;61:69-90. 21. Ohfuji S, Fukushima W, Tanaka T, Habu D, Tamori A, Sakaguchi
2. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C. H, Takeda T, Kawada N, Seki S, Nishiguchi S, Shiomi S, Hirota Y.
Trends in mortality from hepa- tocellular carcinoma in Europe, 1980- Coffee consumption and reduced risk of hepatocellular carcinoma
2004. Hepatology 2008;48:137-45. among patients with chronic type C liver disease: a case-control
3. Chuang SC, La Vecchia C, Boffetta P. Liver cancer: descriptive study. Hepatol Res 2006;36:201-8.
epidemiology and risk factors other than HBV and HCV infection. 22. Leung WW, Ho SC, Chan HL, Wong V, Yeo W, Mok TSK. Moderate
Cancer Lett 2009;286:9-14. coffee consumption reduces the risk of hepatocellular carcinoma
4. Galun D, Basaric D, Zuvela M, Bulajic P, Bogdanovic A, Bidzic N, in hepatitis B chronic carriers: a case-control study. J Epidemiol

Hepatoma Research | Volume 2 | March 9, 2016 75